+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Myopia & Presbyopia Treatment Market by Treatment (Contact Lenses, Medication, Prescription Lenses), Indication (Myopia, Presbyopia) - Forecast 2024-2030

  • PDF Icon

    Report

  • 198 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5012905
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Myopia & Presbyopia Treatment Market size was estimated at USD 19.47 billion in 2023, USD 20.90 billion in 2024, and is expected to grow at a CAGR of 7.84% to reach USD 33.04 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Myopia & Presbyopia Treatment Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Myopia & Presbyopia Treatment Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Myopia & Presbyopia Treatment Market, highlighting leading vendors and their innovative profiles. These include ABB Optical Group, AbbVie Inc., Accu-Lens Inc., Alcon Vision LLC, Arctic Vision, Bausch & Lomb Incorporated by Bausch Health Companies Inc., Carl Zeiss AG, CooperVision, Inc., Essilor Group, Euclid Systems Corporation, Eyenovia, Inc., Haag-Streit Group, Johnson & Johnson Vision, Menicon Co., Ltd., Nidek Co. Ltd., Topcon Corporation, Tylock-George Eye Care & Laser Center, and Ziemer Ophthalmic Systems AG.

Market Segmentation & Coverage

This research report categorizes the Myopia & Presbyopia Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Treatment
    • Contact Lenses
    • Medication
    • Prescription Lenses
    • Surgery
  • Indication
    • Myopia
    • Presbyopia
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Myopia & Presbyopia Treatment Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Myopia & Presbyopia Treatment Market?
  3. What are the technology trends and regulatory frameworks in the Myopia & Presbyopia Treatment Market?
  4. What is the market share of the leading vendors in the Myopia & Presbyopia Treatment Market?
  5. Which modes and strategic moves are suitable for entering the Myopia & Presbyopia Treatment Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Myopia & Presbyopia Treatment Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing Prevalence of Vision Impairment
5.1.1.2. Rising Geriatric Population
5.1.1.3. Minimally Invasive Alternative for Presbyopia Correction
5.1.2. Restraints
5.1.2.1. Lack of Early Diagnosis and Product Recalls
5.1.3. Opportunities
5.1.3.1. Increasing Market Amalgamation Activity
5.1.3.2. Emerging Developments with Introduction of Advanced Lenses such as Implantable Contact Lenses
5.1.4. Challenges
5.1.4.1. High Cost Associated with the Treatment
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Myopia & Presbyopia Treatment Market, by Treatment
6.1. Introduction
6.2. Contact Lenses
6.3. Medication
6.4. Prescription Lenses
6.5. Surgery
7. Myopia & Presbyopia Treatment Market, by Indication
7.1. Introduction
7.2. Myopia
7.3. Presbyopia
8. Americas Myopia & Presbyopia Treatment Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Myopia & Presbyopia Treatment Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Myopia & Presbyopia Treatment Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player
12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. ABB Optical Group
12.1.2. AbbVie Inc.
12.1.3. Accu-Lens Inc.
12.1.4. Alcon Vision LLC
12.1.5. Arctic Vision
12.1.6. Bausch & Lomb Incorporated by Bausch Health Companies Inc.
12.1.7. Carl Zeiss AG
12.1.8. CooperVision, Inc.
12.1.9. Essilor Group
12.1.10. Euclid Systems Corporation
12.1.11. Eyenovia, Inc.
12.1.12. Haag-Streit Group
12.1.13. Johnson & Johnson Vision
12.1.14. Menicon Co., Ltd.
12.1.15. Nidek Co. Ltd.
12.1.16. Topcon Corporation
12.1.17. Tylock-George Eye Care & Laser Center
12.1.18. Ziemer Ophthalmic Systems AG
12.2. Key Product Portfolio
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
List of Figures
FIGURE 1. MYOPIA & PRESBYOPIA TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, 2023 VS 2030
FIGURE 3. MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. MYOPIA & PRESBYOPIA TREATMENT MARKET DYNAMICS
FIGURE 7. MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
FIGURE 8. MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 10. MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. MYOPIA & PRESBYOPIA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 20. MYOPIA & PRESBYOPIA TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. MYOPIA & PRESBYOPIA TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 6. MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY CONTACT LENSES, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY MEDICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY PRESCRIPTION LENSES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 11. MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY MYOPIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY PRESBYOPIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. AMERICAS MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 14. AMERICAS MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 15. AMERICAS MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 16. ARGENTINA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 17. ARGENTINA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 18. BRAZIL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 19. BRAZIL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 20. CANADA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 21. CANADA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 22. MEXICO MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 23. MEXICO MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 24. UNITED STATES MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 25. UNITED STATES MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 26. UNITED STATES MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 27. ASIA-PACIFIC MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 28. ASIA-PACIFIC MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 29. ASIA-PACIFIC MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 30. AUSTRALIA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 31. AUSTRALIA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 32. CHINA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 33. CHINA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 34. INDIA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 35. INDIA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 36. INDONESIA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 37. INDONESIA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 38. JAPAN MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 39. JAPAN MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 40. MALAYSIA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 41. MALAYSIA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 42. PHILIPPINES MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 43. PHILIPPINES MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 44. SINGAPORE MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 45. SINGAPORE MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 46. SOUTH KOREA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 47. SOUTH KOREA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 48. TAIWAN MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 49. TAIWAN MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 50. THAILAND MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 51. THAILAND MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 52. VIETNAM MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 53. VIETNAM MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 54. EUROPE, MIDDLE EAST & AFRICA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 55. EUROPE, MIDDLE EAST & AFRICA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 56. EUROPE, MIDDLE EAST & AFRICA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 57. DENMARK MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 58. DENMARK MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 59. EGYPT MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 60. EGYPT MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 61. FINLAND MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 62. FINLAND MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 63. FRANCE MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 64. FRANCE MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 65. GERMANY MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 66. GERMANY MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 67. ISRAEL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 68. ISRAEL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 69. ITALY MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 70. ITALY MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 71. NETHERLANDS MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 72. NETHERLANDS MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 73. NIGERIA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 74. NIGERIA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 75. NORWAY MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 76. NORWAY MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 77. POLAND MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 78. POLAND MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 79. QATAR MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 80. QATAR MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 81. RUSSIA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 82. RUSSIA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 83. SAUDI ARABIA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 84. SAUDI ARABIA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 85. SOUTH AFRICA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 86. SOUTH AFRICA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 87. SPAIN MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 88. SPAIN MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 89. SWEDEN MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 90. SWEDEN MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 91. SWITZERLAND MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 92. SWITZERLAND MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 93. TURKEY MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 94. TURKEY MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 95. UNITED ARAB EMIRATES MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 96. UNITED ARAB EMIRATES MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 97. UNITED KINGDOM MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 98. UNITED KINGDOM MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 99. MYOPIA & PRESBYOPIA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 100. MYOPIA & PRESBYOPIA TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
TABLE 101. MYOPIA & PRESBYOPIA TREATMENT MARKET LICENSE & PRICING

Companies Mentioned

  • ABB Optical Group
  • AbbVie Inc.
  • Accu-Lens Inc.
  • Alcon Vision LLC
  • Arctic Vision
  • Bausch & Lomb Incorporated by Bausch Health Companies Inc.
  • Carl Zeiss AG
  • CooperVision, Inc.
  • Essilor Group
  • Euclid Systems Corporation
  • Eyenovia, Inc.
  • Haag-Streit Group
  • Johnson & Johnson Vision
  • Menicon Co., Ltd.
  • Nidek Co. Ltd.
  • Topcon Corporation
  • Tylock-George Eye Care & Laser Center
  • Ziemer Ophthalmic Systems AG

Methodology

Loading
LOADING...

Table Information